218 related articles for article (PubMed ID: 11290553)
1. Deletion of 11q23 and cyclin D1 overexpression are frequent aberrations in parathyroid adenomas.
Hemmer S; Wasenius VM; Haglund C; Zhu Y; Knuutila S; Franssila K; Joensuu H
Am J Pathol; 2001 Apr; 158(4):1355-62. PubMed ID: 11290553
[TBL] [Abstract][Full Text] [Related]
2. Chromosome 11 genomic changes in parathyroid adenoma and hyperplasia: array CGH, FISH, and tissue microarrays.
Yi Y; Nowak NJ; Pacchia AL; Morrison C
Genes Chromosomes Cancer; 2008 Aug; 47(8):639-48. PubMed ID: 18398822
[TBL] [Abstract][Full Text] [Related]
3. Expression of cyclin D1 in parathyroid carcinomas, adenomas, and hyperplasias: a paraffin immunohistochemical study.
Vasef MA; Brynes RK; Sturm M; Bromley C; Robinson RA
Mod Pathol; 1999 Apr; 12(4):412-6. PubMed ID: 10229506
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemistry of cyclin D1 and beta-catenin, and mutational analysis of exon 3 of beta-catenin gene in parathyroid adenomas.
Ikeda S; Ishizaki Y; Shimizu Y; Fujimori M; Ojima Y; Okajima M; Sugino K; Asahara T
Int J Oncol; 2002 Mar; 20(3):463-6. PubMed ID: 11836555
[TBL] [Abstract][Full Text] [Related]
5. Cyclin D1/PRAD1 expression in parathyroid adenomas: an immunohistochemical study.
Hsi ED; Zukerberg LR; Yang WI; Arnold A
J Clin Endocrinol Metab; 1996 May; 81(5):1736-9. PubMed ID: 8626826
[TBL] [Abstract][Full Text] [Related]
6. Expression of PRAD1/cyclin D1, retinoblastoma gene products, and Ki67 in parathyroid hyperplasia caused by chronic renal failure versus primary adenoma.
Tominaga Y; Tsuzuki T; Uchida K; Haba T; Otsuka S; Ichimori T; Yamada K; Numano M; Tanaka Y; Takagi H
Kidney Int; 1999 Apr; 55(4):1375-83. PubMed ID: 10201002
[TBL] [Abstract][Full Text] [Related]
7. [Chromosome abnormalities in hyperparathyroidism: utility of comparative genomic hybridization in the study of parathyroid hyperplasias].
Afonso S; Cigudosa JC; Santamaría I; Otero A; Menárguez J; García Miranda JL
Nefrologia; 2003; 23 Suppl 2():2-6. PubMed ID: 12778845
[TBL] [Abstract][Full Text] [Related]
8. Molecular pathogenesis of primary hyperparathyroidism.
Arnold A; Shattuck TM; Mallya SM; Krebs LJ; Costa J; Gallagher J; Wild Y; Saucier K
J Bone Miner Res; 2002 Nov; 17 Suppl 2():N30-6. PubMed ID: 12412775
[TBL] [Abstract][Full Text] [Related]
9. Novel chromosomal abnormalities identified by comparative genomic hybridization in parathyroid adenomas.
Palanisamy N; Imanishi Y; Rao PH; Tahara H; Chaganti RS; Arnold A
J Clin Endocrinol Metab; 1998 May; 83(5):1766-70. PubMed ID: 9589690
[TBL] [Abstract][Full Text] [Related]
10. Multiple genetic aberrations including evidence of chromosome 11q13 rearrangement detected in pituitary adenomas by comparative genomic hybridization.
Metzger AK; Mohapatra G; Minn YA; Bollen AW; Lamborn K; Waldman FM; Wilson CB; Feuerstein BG
J Neurosurg; 1999 Feb; 90(2):306-14. PubMed ID: 9950502
[TBL] [Abstract][Full Text] [Related]
11. Loss of the retinoblastoma tumor-suppressor gene in parathyroid carcinoma.
Cryns VL; Thor A; Xu HJ; Hu SX; Wierman ME; Vickery AL; Benedict WF; Arnold A
N Engl J Med; 1994 Mar; 330(11):757-61. PubMed ID: 7906387
[TBL] [Abstract][Full Text] [Related]
12. Loss of parafibromin expression in a subset of parathyroid adenomas.
Juhlin C; Larsson C; Yakoleva T; Leibiger I; Leibiger B; Alimov A; Weber G; Höög A; Villablanca A
Endocr Relat Cancer; 2006 Jun; 13(2):509-23. PubMed ID: 16728578
[TBL] [Abstract][Full Text] [Related]
13. Parathyroid tumor suppressor on 1p: analysis of the p18 cyclin-dependent kinase inhibitor gene as a candidate.
Tahara H; Smith AP; Gaz RD; Zariwala M; Xiong Y; Arnold A
J Bone Miner Res; 1997 Sep; 12(9):1330-4. PubMed ID: 9286748
[TBL] [Abstract][Full Text] [Related]
14. Cytogenetic and molecular analyses of multiple endocrine neoplasias of the MEN1 syndrome.
Pourani J; Kaserer K; Pfragner R
Int J Oncol; 2002 May; 20(5):971-6. PubMed ID: 11956591
[TBL] [Abstract][Full Text] [Related]
15. Frequent loss of chromosome arm 1p DNA in parathyroid adenomas.
Cryns VL; Yi SM; Tahara H; Gaz RD; Arnold A
Genes Chromosomes Cancer; 1995 May; 13(1):9-17. PubMed ID: 7541648
[TBL] [Abstract][Full Text] [Related]
16. Distinct target regions for chromosome 1p deletions in parathyroid adenomas and carcinomas.
Välimäki S; Forsberg L; Farnebo LO; Larsson C
Int J Oncol; 2002 Oct; 21(4):727-35. PubMed ID: 12239610
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of the calcium sensing receptor and combined loss of chromosomes 1q and 11q in parathyroid carcinoma.
Haven CJ; van Puijenbroek M; Karperien M; Fleuren GJ; Morreau H
J Pathol; 2004 Jan; 202(1):86-94. PubMed ID: 14694525
[TBL] [Abstract][Full Text] [Related]
18. Analysis of parathyroid neoplasms by interphase fluorescence in situ hybridization.
Erickson LA; Jalal SM; Harwood A; Shearer B; Jin L; Lloyd RV
Am J Surg Pathol; 2004 May; 28(5):578-84. PubMed ID: 15105644
[TBL] [Abstract][Full Text] [Related]
19. Genomic localization of novel candidate tumor suppressor gene loci in human parathyroid adenomas.
Tahara H; Smith AP; Gas RD; Cryns VL; Arnold A
Cancer Res; 1996 Feb; 56(3):599-605. PubMed ID: 8564978
[TBL] [Abstract][Full Text] [Related]
20. The role of pRB, p16 and cyclin D1 in colonic carcinogenesis.
Ayhan S; Isisag A; Saruc M; Nese N; Demir MA; Kucukmetin NT
Hepatogastroenterology; 2010; 57(98):251-6. PubMed ID: 20583423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
